← Back to Search

Communication with basic table for High Blood Pressure

N/A
Waitlist Available
Led By Wandi Bruine de Bruin, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up questionnaire completed immediately after receiving communication
Awards & highlights

Study Summary

Hypertension is a major risk factor for cardiovascular disease, and a leading cause of death worldwide. Only about 50% of hypertension patients have good blood pressure control, perhaps because they find it hard to understand their blood pressure readings. The investigators will evaluate ways to help hypertension patients to interpret their blood pressure readings and motivate blood pressure control. Aim 1: Based on existing communications, the investigators will create 3 blood pressure communications: (A) a basic table showing only the normal blood pressure range, which is often used in clinical practice and online communications about blood pressure, but may make it hard to interpret numbers outside of the normal range, potentially undermining behavior change intentions; (B) an enhanced table showing how combinations of diastolic and systolic blood pressure reflect normal, elevated and hypertension ranges, from the American Heart Association; (C) an enhanced graph to be adapted from Blood Pressure UK to show the same color-coded ranges as the enhanced table, with diastolic blood pressure on the x-axis and systolic blood pressure on the y-axis. Aim 2: : Among 650 diagnosed hypertension patients recruited through the University of Pittsburgh Medical Center (UPMC) Pitt+Me Patient Registry, the investigators will evaluate whether being presented with the enhanced table or graph (vs. basic table) affects patients' self-reported blood pressure measurement (as averaged across two measurements taken at the time of the survey at least 1 minute apart, as per directions of the American Heart Association), and improves interpretations of these two blood pressure readings and of hypothetical blood pressure readings, as well as behavior change intentions. Aim 3: The investigators will examine whether Aim 2 findings vary by health literacy, age, and SES.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~questionnaire completed immediately after receiving communication
This trial's timeline: 3 weeks for screening, Varies for treatment, and questionnaire completed immediately after receiving communication for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Behavioral Intention Index (Provided on Questionnaire)
Evaluation of Blood Pressure Reading (Provided on Questionnaire)
Number of Participants Who Measured Blood Pressure as Instructed (Assessed on Questionnaire)
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Communication with enhanced tableExperimental Treatment1 Intervention
Communication showing an enhanced table (Fig 1B) with more reference information for interpreting blood pressure readings, including how combinations of diastolic and systolic blood pressure reflect normal, elevated and hypertension ranges (adapted from the American Heart Association)
Group II: Communication with enhanced graphExperimental Treatment1 Intervention
Communication showing an enhanced graph (adapted from Blood Pressure UK) for interpreting blood pressure readings, showing the same color-coded ranges as the enhanced table, with diastolic blood pressure on the x-axis and systolic blood pressure on the y-axis
Group III: Communication with basic tableExperimental Treatment1 Intervention
Blood pressure communication showing a basic table representing only the normal range of blood pressure readings

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
906 Previous Clinical Trials
1,595,507 Total Patients Enrolled
University of PittsburghOTHER
1,726 Previous Clinical Trials
16,305,201 Total Patients Enrolled
Wandi Bruine de Bruin, PhDPrincipal InvestigatorUniversity of Southern California

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~176 spots leftby May 2025